Search Results - "Baladi, JF" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

PSY15 ECONOMIC IMPLICATIONS OF IRON CHELATION IN PATIENTS WITH REFRACTORY ANEMIA RELATED TO MYELODYSPLASTIC SYNDROME

PSY15 ECONOMIC IMPLICATIONS OF IRON CHELATION IN PATIENTS WITH REFRACTORY ANEMIA RELATED TO MYELODYSPLASTIC SYNDROME

by Migliaccio-Walle, K, Baladi, JF
Published in Value in health (2008)

Get full text

Journal Article

Economic analysis of basiliximab in renal transplantation

Economic analysis of basiliximab in renal transplantation

by Keown, P A, Balshaw, R, Krueger, H, Baladi, J F
Published in Transplantation (15.06.2001)

Get more information

Journal Article

PMC27 THE DEVELOPMENT OF A TREATMENT SATISFACTION QUESTIONNAIRE FOR IRON OVERLOAD (IO) PATIENTS ON CHELATION THERAPY (CT)

PMC27 THE DEVELOPMENT OF A TREATMENT SATISFACTION QUESTIONNAIRE FOR IRON OVERLOAD (IO) PATIENTS ON CHELATION THERAPY (CT)

by Abetz, L, Baladi, JF, Jones, P, Rofail, D
Published in Value in health (01.11.2005)

Get full text

Journal Article

PHM8 THE POTENTIAL IMPACT OF CHELATION THERAPY (CT) ON THE QUALITY OF LIFE (QOL) OF PATIENTS WITH IRON OVERLOAD (IO)

PHM8 THE POTENTIAL IMPACT OF CHELATION THERAPY (CT) ON THE QUALITY OF LIFE (QOL) OF PATIENTS WITH IRON OVERLOAD (IO)

by Abetz, L, Jones, P, Baladi, JF
Published in Value in health (01.11.2005)

Get full text

Journal Article

PCN2 COST-EFFECTIVENESS OF IMATINIB (GLEEVEC)AS FIRST-LINE TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)

PCN2 COST-EFFECTIVENESS OF IMATINIB (GLEEVEC)AS FIRST-LINE TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)

by El Ouagari, K, Talbot, W, Baladi, JF
Published in Value in health (01.11.2004)

Get full text

Journal Article

PNP17 COMPLIANCE OF TWO TREATMENTS OF ALZHEIMER'S DISEASE

PNP17 COMPLIANCE OF TWO TREATMENTS OF ALZHEIMER'S DISEASE

by Barbeau, M, Baladi, JF
Published in Value in health (01.11.2002)

Get full text

Journal Article

PHM1 COST-EFFECTIVENESS OF ONCE-DAILY ORAL CHELATION THERAPY WITH DEFERASIROX VERSUS INFUSIONAL DEFEROXAMINE IN TRANSFUSION-DEPENDENT THALASSEMIA PATIENTS

PHM1 COST-EFFECTIVENESS OF ONCE-DAILY ORAL CHELATION THERAPY WITH DEFERASIROX VERSUS INFUSIONAL DEFEROXAMINE IN TRANSFUSION-DEPENDENT THALASSEMIA PATIENTS

by Delea, T, Sofrygin, O, Thomas, S, Baladi, JF, Phatak, P, Coates, TD
Published in Value in health (01.05.2006)

Get full text

Journal Article

PHM4 COSTS AND CONSEQUENCES OF INADEQUATE COMPLIANCE WITH DEFEROXAMINE THERAPY IN PATIENTS WITH TRANSFUSION-DEPENDENT THALASSEMIA

PHM4 COSTS AND CONSEQUENCES OF INADEQUATE COMPLIANCE WITH DEFEROXAMINE THERAPY IN PATIENTS WITH TRANSFUSION-DEPENDENT THALASSEMIA

by Delea, T, Sofrygin, O, Thomas, S, Baladi, JF, Coates, TD, Phatak, P
Published in Value in health (01.05.2006)

Get full text

Journal Article

PHP15: IMPACT OF FIRST GENERIC ENTRANTS ON BRAND NAME PRODUCTS

by Kleinstiver, P, Baladi, JF
Published in Value in health (01.09.2001)

Get full text

Journal Article

PSY53 SATISFACTION WITH IRON CHELATION THERAPY IS ASSOCIATED WITH IMPROVED QUALITY OF LIFE IN PATIENTS WITH IRON OVERLOAD

PSY53 SATISFACTION WITH IRON CHELATION THERAPY IS ASSOCIATED WITH IMPROVED QUALITY OF LIFE IN PATIENTS WITH IRON OVERLOAD

by Rofail, D, Abetz, L, Heelis, R, Baladi, JF
Published in Value in health (2008)

Get full text

Journal Article

The economic evaluation of pharmacotherapies for Parkinson's disease

The economic evaluation of pharmacotherapies for Parkinson's disease

by Coyle, D., Barbeau, M., Guttman, M., Baladi, J.-F.
Published in Parkinsonism & related disorders (01.06.2003)

Get full text

Journal Article

PMT13: TRANSFERING THE RESULTS FROM ECONOMIC EVALUATIONS: THE USE OF BASILIXIMAB IN TRANSPLANT PATIENTS

PMT13: TRANSFERING THE RESULTS FROM ECONOMIC EVALUATIONS: THE USE OF BASILIXIMAB IN TRANSPLANT PATIENTS

by Lee, KM, Coyle, D, Baladi, JF
Published in Value in health (01.03.2000)

Get full text

Journal Article

The revised Canadian Guidelines for the Economic Evaluation of Pharmaceuticals

The revised Canadian Guidelines for the Economic Evaluation of Pharmaceuticals

by Glennie, J L, Torrance, G W, Baladi, J F, Berka, C, Hubbard, E, Menon, D, Otten, N, Rivière, M
Published in PharmacoEconomics (01.05.1999)

Get full text

Journal Article

A comparative review of pharmacoeconomic guidelines

A comparative review of pharmacoeconomic guidelines

by Jacobs, P, Bachynsky, J, Baladi, J F
Published in PharmacoEconomics (01.09.1995)

Get more information

Journal Article

An economic evaluation of finasteride for treatment of benign prostatic hyperplasia

An economic evaluation of finasteride for treatment of benign prostatic hyperplasia

by Baladi, J F, Menon, D, Otten, N
Published in PharmacoEconomics (01.05.1996)

Get more information

Journal Article

Rivastigmine for alzheimer's disease: Canadian interpretation of intermediate outcome measures and cost implications

Rivastigmine for alzheimer's disease: Canadian interpretation of intermediate outcome measures and cost implications

by Baladi, Jean-François, Bailey, Peter A.B., Black, Sandra, Bouchard, Rémi W., Farcnik, Karl D., Gauthier, Serge, Kertesz, Andrew, Mohr, Erich, Robillard, Alain
Published in Clinical therapeutics (01.12.2000)

Get full text

Journal Article

Biases in cost measurement for economic evaluation studies in health care

Biases in cost measurement for economic evaluation studies in health care

by Jacobs, Philip, Baladi, Jean-François
Published in Health economics (01.11.1996)

Get full text

Journal Article

MGA6 Survey Strategies in the Revision of the Guidelines for Economic Evaluation: Canada

MGA6 Survey Strategies in the Revision of the Guidelines for Economic Evaluation: Canada

by Glennie, JL, Baladi, JF, Berka, C, Hubbard, E, Menon, D, Otten, N, Riviere, M, Torrance, G
Published in Value in health (01.05.1998)

Get full text

Journal Article